Pulse Steroid Injection in Refractory Rheumatoid Arthritis

Sohag University268 enrolled

Overview

Remission or low disease activity in active rheumatoid arthritis

Assessment of rheumatoid arthritis activity by Disease activity score DAS28, DAS28 Erythrocyte sedimentation rate (ESR), American college of rheumatology (ACR) 20, ACR 50, ACR 70 will be done at baseline and every month for 3 consecutive months for both groups.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

268

Conditions

Active Rheumatoid Arthritis

Interventions

SolumedrolDRUG

125 mg methylprednisolone intravenous pulse on 2 consecutive days

Eligibility

Sex: ALLMin age: 20 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Refractory rheumatoid arthritis patients Exclusion Criteria: * Other connective tissue diseases * Endocrine diseases such as DM and thyroid disorders

Locations (1)

Al-Azhar Univrsity

Cairo, Egypt

RECRUITING

Outcomes

Primary Outcomes

remission or low disease activity

Outcome measurements for both groups will be done at baseline and every month for 3 months. DAS28, DAS28 ESR ACR20 ACR50 ACR70

Time frame: 4 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.